Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talampanel with RT and Temozolomide in Newly Diagnosed Glioblastoma
NCT00267592Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2005
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talampanel in glioblastoma multiforme (GBM), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2005; status: completed.
02
Drugs
talampanel
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00267592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267592.